We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.28%
AUM
$222M
AUM Growth
-$1.44M
Cap. Flow
+$3.73M
Cap. Flow %
1.69%
Top 10 Hldgs %
33.52%
Holding
116
New
2
Increased
28
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$3.71M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.12M
3
INCY icon
Incyte
INCY
+$1.92M
4
BMY icon
Bristol-Myers Squibb
BMY
+$678K
5
VTV icon
Vanguard Morningstar Value ETF
VTV
+$332K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$5.42M
2
ADBE icon
Adobe
ADBE
+$189K
3
MSFT icon
Microsoft
MSFT
+$167K
4
QCOM icon
Qualcomm
QCOM
+$162K
5
HBAN icon
Huntington Bancshares
HBAN
+$162K

Sector Composition

Rank Sector Weight
1 Technology 32.38%
2 Healthcare 28.32%
3 Industrials 11.46%
4 Financials 8.63%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$14.5M 6.56%
102,672
-483
-0.5% -$71.1K
MSFT icon
2
Microsoft
MSFT
$3.45T
$10.1M 4.58%
35,995
-573
-2% -$167K
INFY icon
3
Infosys
INFY
$48.7B
$7.41M 3.34%
332,895
-2,672
-0.8% -$60.4K
QCOM icon
4
Qualcomm
QCOM
$155B
$7.03M 3.17%
54,463
-1,145
-2% -$162K
TROW icon
5
T. Rowe Price
TROW
$23.9B
$6.98M 3.15%
35,488
-755
-2% -$159K
REGN icon
6
Regeneron Pharmaceuticals
REGN
$78.5B
$6.84M 3.09%
11,299
-140
-1% -$86.9K
NTAP icon
7
NetApp
NTAP
$35B
$5.95M 2.68%
66,277
-1,447
-2% -$122K
META icon
8
Meta Platforms (Facebook)
META
$1.42T
$5.52M 2.49%
16,254
+134
+0.8% +$48.3K
EXPD icon
9
Expeditors International
EXPD
$22B
$5.07M 2.29%
42,594
-230
-0.5% -$28.8K
GILD icon
10
Gilead Sciences
GILD
$162B
$4.8M 2.17%
68,769
+306
+0.4% +$21.5K
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$121B
$4.29M 1.94%
23,680
+16,005
+209% +$3.12M
CSCO icon
12
Cisco
CSCO
$457B
$4.19M 1.89%
77,060
-1,033
-1% -$58K
CHRW icon
13
C.H. Robinson
CHRW
$17.4B
$4.04M 1.82%
46,410
-317
-0.7% -$28.7K
ADBE icon
14
Adobe
ADBE
$99.5B
$3.95M 1.78%
6,865
-300
-4% -$189K
AZN icon
15
AstraZeneca
AZN
$263B
$3.83M 1.73%
+31,904
New +$3.71M
GSK icon
16
GSK
GSK
$104B
$3.61M 1.63%
75,599
+1,367
+2% +$68.7K
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
$3.54M 1.6%
75,321
-568
-0.7% -$27.4K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.27M 1.47%
11,964
-65
-0.5% -$18.3K
AMGN icon
19
Amgen
AMGN
$208B
$3.18M 1.44%
14,953
-26
-0.2% -$5.98K
CTAS icon
20
Cintas
CTAS
$81.9B
$3.12M 1.41%
32,748
-100
-0.3% -$9.78K
BEN icon
21
Franklin Resources
BEN
$17.6B
$3.11M 1.4%
104,712
-1,544
-1% -$48.2K
BMY icon
22
Bristol-Myers Squibb
BMY
$133B
$3.09M 1.39%
52,151
+10,288
+25% +$678K
EBS icon
23
Emergent Biosolutions
EBS
$373M
$3.06M 1.38%
61,050
+3,750
+7% +$227K
DLB icon
24
Dolby
DLB
$5.51B
$2.99M 1.35%
33,936
-458
-1% -$44.4K
IBM icon
25
IBM
IBM
$211B
$2.95M 1.33%
22,184
-513
-2% -$68.6K
1
2 3 4 5

Similar funds

FAL
Focused Alpha LLC Denver, Colorado $324M AUM
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
CRI
Commonwealth Retirement Investments Richmond, Virginia $323M AUM 24.17% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
GIM
Gold Investment Management Edmonton, Alberta, Canada $323M AUM 38.72% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return

AIMZ Investment Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, AIMZ Investment Advisors held 116 positions worth $222M, down 0.65% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.3%. AIMZ Investment Advisors opened 2 new positions and exited 3, leaving the 116-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • AIMZ Investment Advisors's largest Q3 2021 buy was AstraZeneca: 31,904 shares worth $3.83M.
  • AIMZ Investment Advisors added most to Vertex Pharmaceuticals in Q3 2021, an estimated $3.12M increase.
  • AIMZ Investment Advisors's biggest Q3 2021 reduction was Adobe, cutting an estimated $189K.
  • AIMZ Investment Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $5.42M.
  • AIMZ Investment Advisors's ten largest holdings make up 34% of its $222M portfolio in Q3 2021.
  • AIMZ Investment Advisors opened 2 new positions and closed 3 in Q3 2021.
  • AIMZ Investment Advisors's portfolio value fell 0.65% quarter-over-quarter to $222M.

Based on AIMZ Investment Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.